Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-08-01

Clinical Trial Update: Domperidone Expanded Access Protocol for Patients With Gastrointestinal Disorders

View source ↗

Summary

Clinical trial update indicates that the expanded access protocol for domperidone in gastrointestinal disorders is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Domperidone (domperidone)

Snippet

Sponsor: Prasanna K Kapavarapu | Conditions: Gastroesophageal Reflux, Gastroparesis | Status: NO_LONGER_AVAILABLE